D
Revolution Medicines, Inc. RVMD
$39.12 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -20.45% -44.13% -35.54% -70.35% -185.87%
Total Depreciation and Amortization 20.68% 39.67% 65.10% 10.30% 11.27%
Total Amortization of Deferred Charges 0.00% 0.00% 0.00% 0.00% 0.00%
Total Other Non-Cash Items -35.90% 48.47% -13.78% -101.75% 196.30%
Change in Net Operating Assets 98.62% 478.72% -122.28% -1,500.98% 255.51%
Cash from Operations -14.70% -29.77% -90.95% -157.34% -95.12%
Capital Expenditure 47.26% -38.86% -114.39% -80.15% 19.44%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -3.60% -122.47% 360.09% -4,354.41% -8,842.41%
Cash from Investing -3.29% -127.75% 347.90% -6,305.36% -5,254.76%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 30,461.63% 7,545.30% -88.39% -99.75% -95.04%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -88.62% -- -- -- 2,001,885.71%
Cash from Financing 4.10% 7,545.30% -88.39% -99.75% 1,534.16%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1.25% -237.01% 72.37% -253.39% 2,030.45%
Weiss Ratings